Discover

RLYB
Rallybio Corporation
16.54
1 x 16.34
1 x 16.60
bid
ask
-
0.07
0.40%
01:40 PM
timesize
Ytd201.33%
1y315.65%
16.40
day range
16.60
3.20
52 week range
17.57
Open16.57Prev Close16.61Low16.40High16.60Mkt Cap87.79M
Vol3.06KAvg Vol53.57KEPS-3.80P/E-4.35Forward P/E-0.72
Beta-0.90Short Ratio5.26Inst. Own76.27%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0750-d Avg16.03200-d Avg9.651yr Est8.25
Income Statement
Operating Expenses5.65M
Research and Development Expense758.00K
Selling, General and Administrative Expense4.89M
Operating Income-5.65M
Income Tax Expense1.32M
Net Income43.67M
Net Income Common Stock43.67M
Net Income Common Stock (USD)43.67M
Consolidated Income43.67M
Earnings per Basic Share7.66
Earnings per Basic Share (USD)7.66
Earnings per Diluted Share7.53
Earning Before Interest & Taxes (EBIT)44.99M
Earning Before Interest & Taxes (USD)44.99M
Weighted Average Shares5.70M
Weighted Average Shares Diluted5.80M
Balance Sheet
Cash and Equivalents92.85M
Cash and Equivalents (USD)92.85M
Current Assets97.25M
Total Assets98.06M
Current Liabilities3.57M
Total Liabilities3.57M
Accumulated Retained Earnings (Deficit)-266.61M
Shareholders Equity94.50M
Shareholders Equity (USD)94.50M
Assets Non-Current810.00K
Trade and Non-Trade Payables833.00K
Tax Liabilities1.27M
Cash Flow
Depreciation, Amortization & Accretion2.00K
Net Cash Flow from Financing131.00K
Net Cash Flow / Change in Cash & Cash Equivalents51.55M
Issuance (Purchase) of Equity Shares131.00K
Net Cash Flow from Investing5.50M
Net Cash Flow - Investment Acquisitions and Disposals5.50M
Net Cash Flow from Operations45.92M
Share Based Compensation424.00K